9408

543524

RAINBOW

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

RAINBOW CHILDRENS MED LTD Share Price Today

RAINBOW CHILDRENS MED LTD is currently trading at ₹1365, up by ₹25.09 from the previous close. The stock touched an intraday high of ₹1368.00 and a low of ₹1340.00 during the latest trading session. Over the past one year, RAINBOW CHILDRENS MED LTD has delivered a loss of 6.39%, while the stock has gained 8.05% in the last one month.

RAINBOW CHILDRENS MED LTD performance

Today’s low Today’s high
₹ 1340.00 ₹ 1368.00
₹ 1365.00
52 week low 52 week high
₹ 1084.00 ₹ 1645.70
₹ 1365.00
Open Price ₹ 1340.00
Prev. Close ₹ 1339.90
Volume (Shares) 72355.00
Total traded value ₹ 987.64
Upper Circuit ₹ 1607.80
Lower Circuit ₹ 1072.00
info

Investment Returns

Over 1 Month 8.05% Over 3 Months 16.26% Over 6 Months -1.42% Over 1 Year -6.39%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

RAINBOW CHILDRENS MED LTD fundamentals


  • Market cap (Cr) 13,862.80
  • P/E Ratio (TTM) 55.39
  • Beta 0.54
  • Book Value / share 166.31
  • Return on equity 17.13%
  • EPS (TTM) 24.73
  • Dividend yield 0.26%
  • Net profit/quarter (Cr) 59.31
info icon alternate text
  • Market cap (Cr) 13,849.10
  • P/E Ratio (TTM) 55.39
  • Beta 0.45
  • Book Value / share 166.31
  • Return on equity 17.13%
  • EPS (TTM) 24.73
  • Dividend yield 0.26%
  • Net profit/quarter (Cr) 59.31
info icon alternate text

RAINBOW CHILDRENS MED LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 408.06
Operating Expense 333.29
Net Profit 59.31
Net Profit Margin (%) 14.53
Earnings Per Share (EPS) 5.85
EBITDA 132.63
Effective Tax Rate (%) 24.42
Particulars DEC 2025 (Values in Cr)
Revenue 394.35
Operating Expense 316.67
Net Profit 65.82
Net Profit Margin (%) 16.69
Earnings Per Share (EPS) 6.48
EBITDA 141.43
Effective Tax Rate (%) 25.56
Particulars SEP 2025 (Values in Cr)
Revenue 408.50
Operating Expense 318.27
Net Profit 73.17
Net Profit Margin (%) 17.91
Earnings Per Share (EPS) 7.20
EBITDA 148.89
Effective Tax Rate (%) 25.64
Particulars JUN 2025 (Values in Cr)
Revenue 334.75
Operating Expense 285.21
Net Profit 51.72
Net Profit Margin (%) 15.45
Earnings Per Share (EPS) 5.09
EBITDA 118.80
Effective Tax Rate (%) 24.84
Particulars MAR 2025 (Values in Cr)
Revenue 354.00
Operating Expense 293.15
Net Profit 54.54
Net Profit Margin (%) 15.40
Earnings Per Share (EPS) 5.37
EBITDA 124.72
Effective Tax Rate (%) 27.03
Particulars MAR 2026 (Values in Cr)
Revenue 1545.66
Operating Expense 1253.46
Net Profit 250.02
Net Profit Margin (%) 16.17
Earnings Per Share (EPS) 24.62
EBITDA 541.78
Effective Tax Rate (%) 25.17
Particulars MAR 2025 (Values in Cr)
Revenue 1454.51
Operating Expense 1181.37
Net Profit 237.58
Net Profit Margin (%) 16.33
Earnings Per Share (EPS) 23.40
EBITDA 523.42
Effective Tax Rate (%) 26.23
Particulars MAR 2024 (Values in Cr)
Revenue 1236.56
Operating Expense 984.30
Net Profit 214.89
Net Profit Margin (%) 17.37
Earnings Per Share (EPS) 21.17
EBITDA 450.44
Effective Tax Rate (%) 25.70
Particulars MAR 2023 (Values in Cr)
Revenue 1113.99
Operating Expense 867.76
Net Profit 205.89
Net Profit Margin (%) 18.48
Earnings Per Share (EPS) 20.40
EBITDA 408.62
Effective Tax Rate (%) 24.53
Particulars MAR 2022 (Values in Cr)
Revenue 924.60
Operating Expense 755.68
Net Profit 142.29
Net Profit Margin (%) 15.38
Earnings Per Share (EPS) 15.18
EBITDA 316.74
Effective Tax Rate (%) 25.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 144.58
ROE % 17.91
ROCE % 19.04
Total Debt to Total Equity 0.56
EBITDA Margin 35.97
Particulars MAR 2024 (Values in Cr)
Book Value / Share 124.03
ROE % 18.83
ROCE % 19.48
Total Debt to Total Equity 0.58
EBITDA Margin 36.20
Particulars MAR 2023 (Values in Cr)
Book Value / Share 104.42
ROE % 25.72
ROCE % 24.07
Total Debt to Total Equity 0.69
EBITDA Margin 36.68
Particulars MAR 2022 (Values in Cr)
Book Value / Share 62.93
ROE % 27.00
ROCE % 22.55
Total Debt to Total Equity 1.05
EBITDA Margin 33.56
Particulars MAR 2021 (Values in Cr)
Book Value / Share 99.05
ROE % 9.54
ROCE % 10.90
Total Debt to Total Equity 1.18
EBITDA Margin 26.98
Particulars MAR 2025 (Values in Cr)
Book Value / Share 146.58
ROE % 17.13
ROCE % 18.58
Total Debt to Total Equity 0.53
EBITDA Margin 36.27
Particulars MAR 2024 (Values in Cr)
Book Value / Share 126.62
ROE % 18.11
ROCE % 19.04
Total Debt to Total Equity 0.54
EBITDA Margin 36.69
Particulars MAR 2023 (Values in Cr)
Book Value / Share 107.23
ROE % 24.03
ROCE % 23.23
Total Debt to Total Equity 0.63
EBITDA Margin 36.95
Particulars MAR 2022 (Values in Cr)
Book Value / Share 66.49
ROE % 26.10
ROCE % 22.51
Total Debt to Total Equity 0.93
EBITDA Margin 34.56
Particulars MAR 2021 (Values in Cr)
Book Value / Share 105.78
ROE % 11.23
ROCE % 11.75
Total Debt to Total Equity 1.06
EBITDA Margin 28.91
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 20.27
Total Assets 2376.98
Total Liabilities 2376.98
Total Equity 1475.01
Share Outstanding 10
Price to Book Ratio 9.55
Return on Assets (%) 10.24
Return on Capital (%) 16.5
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 10.12
Total Assets 2170.40
Total Liabilities 2170.40
Total Equity 1264.92
Share Outstanding 10
Price to Book Ratio 10.25
Return on Assets (%) 9.99
Return on Capital (%) 17.16
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 45.50
Total Assets 1776.30
Total Liabilities 1776.30
Total Equity 1064.91
Share Outstanding 10
Price to Book Ratio 6.81
Return on Assets (%) 11.86
Return on Capital (%) 19.8
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 185.21
Total Assets 1295.74
Total Liabilities 1295.74
Total Equity 606.26
Share Outstanding 9
Price to Book Ratio 0.00
Return on Assets (%) 10.67
Return on Capital (%) 21.34
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 94.67
Total Assets 1081.26
Total Liabilities 1081.26
Total Equity 448.37
Share Outstanding 4
Price to Book Ratio 0.00
Return on Assets (%) 3.70
Return on Capital (%) 8.06
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 16.91
Total Assets 2354.22
Total Liabilities 2354.22
Total Equity 1488.54
Share Outstanding 10
Price to Book Ratio 9.55
Return on Assets (%) 10.09
Return on Capital (%) 15.96
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 7.49
Total Assets 2150.43
Total Liabilities 2150.43
Total Equity 1285.25
Share Outstanding 10
Price to Book Ratio 10.25
Return on Assets (%) 9.99
Return on Capital (%) 16.72
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 35.59
Total Assets 1758.75
Total Liabilities 1758.75
Total Equity 1088.38
Share Outstanding 10
Price to Book Ratio 6.81
Return on Assets (%) 11.70
Return on Capital (%) 18.92
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 175.14
Total Assets 1285.36
Total Liabilities 1285.36
Total Equity 636.29
Share Outstanding 9
Price to Book Ratio 0.00
Return on Assets (%) 11.07
Return on Capital (%) 20.99
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 84.75
Total Assets 1069.83
Total Liabilities 1069.83
Total Equity 475.93
Share Outstanding 4
Price to Book Ratio 0.00
Return on Assets (%) 4.61
Return on Capital (%) 9.43
Particulars MAR 2025 (Values in Cr)
Net Income 330.00
Cash from Operations 481.25
Cash from Investing -267.79
Cash from Financing -117.72
Net change in Cash 10.13
Free Cash Flow 626.92
Particulars MAR 2024 (Values in Cr)
Net Income 294.81
Cash from Operations 410.01
Cash from Investing -226.46
Cash from Financing -101.78
Net change in Cash -6.84
Free Cash Flow 763.59
Particulars MAR 2023 (Values in Cr)
Net Income 281.77
Cash from Operations 408.09
Cash from Investing -465.20
Cash from Financing 143.40
Net change in Cash 5.43
Free Cash Flow 549.38
Particulars MAR 2022 (Values in Cr)
Net Income 187.34
Cash from Operations 286.40
Cash from Investing -175.34
Cash from Financing -44.06
Net change in Cash 4.32
Free Cash Flow 348.62
Particulars MAR 2021 (Values in Cr)
Net Income 55.69
Cash from Operations 169.20
Cash from Investing -82.88
Cash from Financing -60.87
Net change in Cash -1.03
Free Cash Flow 245.30
Particulars MAR 2025 (Values in Cr)
Net Income 322.08
Cash from Operations 469.08
Cash from Investing -262.69
Cash from Financing -112.94
Net change in Cash 9.40
Free Cash Flow 612.39
Particulars MAR 2024 (Values in Cr)
Net Income 289.21
Cash from Operations 392.49
Cash from Investing -213.72
Cash from Financing -96.99
Net change in Cash -4.30
Free Cash Flow 744.58
Particulars MAR 2023 (Values in Cr)
Net Income 272.83
Cash from Operations 393.10
Cash from Investing -460.27
Cash from Financing 147.68
Net change in Cash 2.19
Free Cash Flow 532.79
Particulars MAR 2022 (Values in Cr)
Net Income 189.74
Cash from Operations 276.08
Cash from Investing -169.20
Cash from Financing -41.13
Net change in Cash 3.72
Free Cash Flow 334.60
Particulars MAR 2021 (Values in Cr)
Net Income 65.89
Cash from Operations 168.06
Cash from Investing -86.79
Cash from Financing -56.43
Net change in Cash -1.66
Free Cash Flow 243.50
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8496.45 62.45 12.89 122165.91 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 52.38 23.70 2.85 98.17 40.75 77.00
SHREE PACETRONIX LTD. 137.90 16.46 2.90 51.71 66.10 283.15
TRANSGENE BIOTEK LTD. 2.94 0.00 2.65 22.28 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8496.45 81.38 12.26 122165.91 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 38.94 0.00 -9.47 29.09 30.30 57.48
KOVAI MEDICAL CENTER & HO 5803.05 25.97 4.81 6348.54 5010.00 6725.00

RAINBOW CHILDRENS MED LTD shareholding pattern

Holding
11.79%
49.83%
17.23%
21.13%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

RAINBOW CHILDRENS MED LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1365.00 1.87 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 1348.60
  • 26 Days 1331.00
  • 10 Days 1347.30
  • 50 Days 1302.00
  • 12 Days 1346.50
  • 100 Days 1283.70
  • 20 Days 1338.90
  • 200 Days 1303.50
1338.93 PIVOT
First Support 1327.77 First Resistance 1351.07 Second Support 1315.63 Second Resistance 1362.23 Third Support 1304.47 Third Resistance 1374.37
RSI 60.90 ADX 27.17 MACD 15.53 Williams % R -35.71 Commodity Channel Index (CCI) 58.24
Date 2026-06-12 Week 42633.00 Same Day 41423.00 Month 59822.00
1 Year 0.54 3 Year 0.38
Over 1 Month
8.05% down
Over 1 Year
-6.39% down
Over 3 Months
16.26% down
Over 3 Years
13.52% down
Over 6 Months
-1.42% down
Over 5 Years
24.83% down

RAINBOW CHILDRENS MED LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
21 Jul 2026 3.5 Final 21 Jul 2026 Equity shares
27 Jun 2025 3.0 Final 28 Jun 2025 Equity shares
23 Jul 2024 3.0 Final 23 Jul 2024 Equity shares
22 Jun 2023 3.0 Final 22 Jun 2023 Equity shares
07 Sep 2022 2.0 Final 08 Sep 2022 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
21 Jul 2026 3.5 Final 21 Jul 2026 Equity shares
27 Jun 2025 3.0 Final 28 Jun 2025 Equity shares
23 Jul 2024 3.0 Final 23 Jul 2024 Equity shares
22 Jun 2023 3.0 Final 22 Jun 2023 Equity shares
07 Sep 2022 2.0 Final 08 Sep 2022 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Rainbow Childrens Medicare Ltd?

Answer Field

Rainbow Childrens Medicare Ltd share price is for NSE ₹ 1,365.00 & for BSE ₹ 1,364.00 as on Jun 12 2026 03:29 PM.

What is the Market Cap of Rainbow Childrens Medicare Ltd Share?

Answer Field

The market cap of Rainbow Childrens Medicare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 12 2026 03:29 PM.

What is the 52 Week High and Low of Rainbow Childrens Medicare Ltd?

Answer Field

The 52 Week High and Low of Rainbow Childrens Medicare Ltd for NSE is ₹ 1,645.70 and ₹ 1,084.00 and for BSE is ₹ 1,644.10 and ₹ 1,008.75.

What is 1 year return for Rainbow Childrens Medicare Ltd?

Answer Field

The 1 year returns on the stock has been -6.39%.

What is the P/E Ratio of Rainbow Childrens Medicare Ltd Share?

Answer Field

As on Jun 12 2026 03:29 PM the price-to-earnings (PE) ratio for Rainbow Childrens Medicare Ltd share is 55.39.

What is the PB ratio of Rainbow Childrens Medicare Ltd Share?

Answer Field

As on Jun 12 2026 03:29 PM, the price-to-book (PB) ratio for Rainbow Childrens Medicare Ltd share is 166.31.

How to Buy Rainbow Childrens Medicare Ltd Share?

Answer Field

You can trade in Rainbow Childrens Medicare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Rainbow Childrens Medicare Ltd Share on Bajaj Broking App?

Answer Field

To buy Rainbow Childrens Medicare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Rainbow Childrens Medicare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|